About Rudra Molecules
Rudra Molecules is a company based in Ahmedabad (India) founded in 2011. Rudra Molecules offers products and services including Active Pharmaceutical Ingredients (APIs) and Excipients.
- Headquarter Ahmedabad, India
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Legal Name Aash Biotech Pvt Ltd
- Date of Incorporation 30 Jan, 2004
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹5.7 Lakh
FY 2016 · -47% YoY
- Net Profit₹3,591
FY 2016 · 1% margin
- EBITDA₹5,221
FY 2016 · 1% margin
Associated legal entities of Rudra Molecules
Rudra Molecules operates through Aash Biotech Private Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2016) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aash Biotech Private Limited CIN U24231GJ2004PTC043534 | Strike Off | 30 Jan 2004 | Ahmedabad, Gujarat | ₹0.1 Cr | – | 2 | View details |
Products & Services of Rudra Molecules
Rudra Molecules offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients (APIs) and Excipients.
Sourcing, warehousing, and distribution of APIs are handled for the pharmaceutical and veterinary industries.
Excipients are supplied as part of the components for pharmaceuticals and related applications.
Board of directors of Aash Biotech Private Limited (Rudra Molecules)
Aash Biotech Private Limited is the primary company behind Rudra Molecules. The board of Aash Biotech Private Limited currently have 2 directors; the longest-serving is Abha Amitabh Verma, appointed in 2004. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Abha Amitabh Verma DIN 02357726 | Director | 30 Jan 2004 | 22 yrs 8 mo | Aash Biotech Private Limited |
| Amitabh Verma DIN 01332165 | Director | 30 Jan 2004 | 22 yrs 8 mo | Aash Biotech Private Limited |
Financials of Rudra Molecules
Figures of Aash Biotech Private Limited, the primary company behind Rudra Molecules, for FY 2016. Revenue was ₹5.7 Lakh (-47% year on year). Net profit was ₹3,591 (1% margin). EBITDA was ₹5,221 (1% margin).
- ₹5.7 LakhRevenue · FY 2016 · -47% YoY
- ₹3,591Net profit · 1% margin
- ₹5,221EBITDA · 1% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Aash Biotech Private Limited are on its company page.
Detailed financial statements for Rudra Molecules
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Rudra Molecules
10 companies that operate in the same segment as Rudra Molecules (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rudra Molecules
Rudra Molecules was founded in 2011.
Rudra Molecules is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
The primary company behind Rudra Molecules, Aash Biotech Private Limited, reported revenue of ₹5.7 Lakh for FY 2016, down 47% year on year.
Rudra Molecules Is Based In Ahmedabad, India, And Is Specialized In The Sourcing, Warehousing, And Distribution Of Active Pharmaceutical Ingredients, Excipients, Finished Pharmaceuticals, Chemicals, And Packaging Components For The Pharmaceutical And Veterinary Industries. It Also Handles The Supply Of Colours And Dyes For Textile And Leather Sectors. The Company Forms Part Of A Group Including Nuclius Lifesciences, Remedy Labs, And Aash Biotech . Products Are Ensured To Adhere To Stringent Quality Parameters, While Efficient Logistics And Administrative Staff Support The Fulfillment Of Customer Requirements Globally.
Rudra Molecules offers Active Pharmaceutical Ingredients (APIs) and Excipients.
Rudra Molecules operates through Aash Biotech Private Limited.
The legal entities of Rudra Molecules currently have 2 directors, including Abha Amitabh Verma, Amitabh Verma.